Phase 1 Study of BPN14770 in Participants With Hepatic Impairment and Healthy Controls
NCT07018492
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatic Impairment
Interventions
DRUG:
BPN14770
Sponsor
Shionogi